IL13RA2 and glioblastoma: IL13Rα2, a monomeric high-affinity IL13 receptor, is selectively expressed on GBM while absent in the surrounding normal brain tissue, rendering it can be proposed as an optimal candidate for target selection of CAR-T cell therapy in glioma (Thaci et al., 2014).